Related Experiment Video
Updated: Jun 23, 2025

Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo
Published on: September 18, 2019
Dasatinib promotes muscle differentiation and disrupts normal muscle regeneration
Nanami Ishida1, Tamaki Kurosawa1, Momo Goto1
1Laboratory of Veterinary Pharmacology, Department of Veterinary Medical Sciences, Graduate School of Agriculture and Life Sciences, Tokyo University, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan.
Abstract:
Dasatinib is one of the second-generation tyrosine kinase inhibitors used to treat chronic myeloid leukemia and has a broad target spectrum, including KIT, PDGFR, and SRC family kinases. Due to its broad drug spectrum, dasatinib has been reported at the basic research level to improve athletic performance by eliminating senescent cell removal and to have an effect on muscle diseases such as Duchenne muscular dystrophy, but its effect on myoblasts has not been investigated. In this study, we evaluated the effects of dasatinib on skeletal muscle both under normal conditions and in the regenerating state. Dasatinib suppressed the proliferation and promoted the fusion of C2C12 myoblasts. During muscle regeneration, dasatinib increased the gene expressions of myogenic-related genes (Myod, Myog, and Mymx), and caused abnormally thin muscle fibers on the CTX-induced muscle injury mouse model. From these results, dasatinib changes the closely regulated gene expression pattern of myogenic regulatory factors during muscle differentiation and disrupts normal muscle regeneration. Our data suggest that when using dasatinib, its effects on skeletal muscle should be considered, particularly at regenerating stages.
Insights
Dasatinib, used for leukemia, disrupts normal muscle regeneration by altering gene expression in myoblasts and muscle fibers. This tyrosine kinase inhibitor impacts skeletal muscle development and repair processes.
Area of Science:
- Biochemistry
- Cell Biology
- Muscle Physiology
Background:
- Dasatinib is a second-generation tyrosine kinase inhibitor with a broad target spectrum.
- Previous research suggests dasatinib may improve athletic performance and affect muscle diseases, but its impact on myoblasts is unknown.
Purpose of the Study:
- To investigate the effects of dasatinib on skeletal muscle under normal and regenerating conditions.
- To determine dasatinib's influence on C2C12 myoblast proliferation and fusion.
Main Methods:
- Utilized C2C12 myoblasts to assess proliferation and fusion.
- Administered dasatinib to a mouse model with CTX-induced muscle injury.
- Analyzed gene expression of myogenic-related factors (Myod, Myog, Mymx).
Main Results:
- Dasatinib suppressed C2C12 myoblast proliferation but promoted fusion.
- Increased gene expression of myogenic regulatory factors during muscle regeneration.
- Induced abnormally thin muscle fibers in a mouse model of muscle injury.
Conclusions:
- Dasatinib alters the gene expression patterns of myogenic regulatory factors during muscle differentiation.
- The drug disrupts normal skeletal muscle regeneration processes.
- Consideration of dasatinib's skeletal muscle effects is crucial, especially during regeneration stages.
More Related Videos
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Inhibition of Cdk Activity
iPS Cell Differentiation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The JAK-STAT Signaling Pathway

